LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial.
about
Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.
P2860
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@en
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@nl
type
label
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@en
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@nl
prefLabel
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@en
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@nl
P2093
P50
P1433
P1476
LpA-I, LpA-I:A-II HDL and CHD- ...... ffairs HDL Intervention Trial.
@en
P2093
Bela F Asztalos
Caitlin E Cox
Dorothea Collins
Ernst J Schaefer
Katalin V Horvath
P356
10.1016/J.ATHEROSCLEROSIS.2005.10.018
P577
2005-11-18T00:00:00Z